EIF4A3-IN-17
EIF4A3-IN-17 (compound 61) is a Silvestrol (HY-13251) analogue. eIF4A3-IN-17 interferes the assembling of eIF4F translation complex with EC50s of 0.9, 15 and 1.8 nM for myc-LUC, tub-LUC and the growth inhibition for MBA-MB-231 cells. eIF4A3-IN-17 can be used for the research of human cancer pathogenesis[1].
Product Specifications
CAS Number
[1402931-75-2]
UNSPSC
12352005
Target
Eukaryotic Initiation Factor (eIF)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/eif4a3-in-17.html
Purity
99.56
Solubility
10 mM in DMSO
Smiles
COC1=CC=C([C@@]23OC4=CC(C#N)=CC(OC)=C4[C@]2(O)[C@@H]([C@@H]([C@H]3C5=CC=CC=C5)C(OC)=O)O)C=C1
Molecular Formula
C28H25NO7
Molecular Weight
487.50
References & Citations
[1]Liu T, et al. Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors. J Med Chem. 2012 Oct 25;55 (20) :8859-78.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CDS1 (Phosphatidate Cytidylyltransferase 1, CDP-DAG Synthase 1, CDP-DG Synthase 1, CDP-diacylglycerol Synthase 1, CDS 1, CDP-diglyceride Pyrophosphorylase 1, CDP-diglyceride Synthase 1, CTP:phosphatidate Cytidylyltransferase 1, CDS) (MaxLight 405)